𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial

✍ Scribed by Gravis, Gwenaelle; Fizazi, Karim; Joly, Florence; Oudard, Stéphane; Priou, Franck; Esterni, Benjamin; Latorzeff, Igor; Delva, Remy; Krakowski, Ivan; Laguerre, Brigitte; Rolland, Fréderic; Théodore, Christine; Deplanque, Gael; Ferrero, Jean Marc; Pouessel, Damien; Mourey, Loïc; Beuzeboc, Philippe; Zanetta, Sylvie; Habibian, Muriel; Berdah, Jean François; Dauba, Jerome; Baciuchka, Marjorie; Platini, Christian; Linassier, Claude; Labourey, Jean Luc; Machiels, Jean Pascal; El Kouri, Claude; Ravaud, Alain; Suc, Etienne; Eymard, Jean Christophe; Hasbini, Ali; Bousquet, Guilhem; Soulie, Michel


Book ID
122041218
Publisher
The Lancet
Year
2013
Tongue
English
Weight
387 KB
Volume
14
Category
Article
ISSN
1470-2045

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Androgen-deprivation therapy alone or wi
✍ Gravis, Gwenaelle; Fizazi, Karim; Joly, Florence; Oudard, Stéphane; Priou, Franc 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 387 KB

## Background: Early chemotherapy might improve the overall outcomes of patients with metastatic non-castrate (ie, hormone-sensitive) prostate cancer. we investigated the effects of the addition of docetaxel to androgen-deprivation therapy (adt) for patients with metastatic non-castrate prostate ca